<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">IJO</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-4738</issn>
      <issn pub-type="epub">1998-3689</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25005204</article-id>
      <article-id pub-id-type="pmc">4131329</article-id>
      <article-id pub-id-type="publisher-id">IJO-62-724</article-id>
      <article-id pub-id-type="doi">10.4103/0301-4738.136236</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Ophthalmology Practice</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bilateral monosymptomatic optic neuritis following <italic>Mycoplasma pneumoniae</italic> infection: A case report and literature review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chiang</surname>
            <given-names>Wei-Yu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Hsiu-Mei</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Hsiu-Mei Huang, Department of Ophthalmology, No. 123, Dapi Rd., Niaosong Dist., Kaohsiung City 83301, Taiwan, Taiwan (R.O.C.). E-mail: <email xlink:href="sammy1013@adm.cgmh.org.tw">sammy1013@adm.cgmh.org.tw</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2014</year>
      </pub-date>
      <volume>62</volume>
      <issue>6</issue>
      <fpage>724</fpage>
      <lpage>727</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>3</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Ophthalmology</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Herein, we report the clinical findings, treatment choice, and clinical course of a rare case of <italic>Mycoplasma pneumoniae (M. pneumoniae)</italic> infection with the sole manifestation of optic neuritis (ON). To the best of our knowledge, this is the first case presenting monosymptomatic visual loss without papillitis, neurological symptoms, and abnormal findings on brain imaging. Related articles about ON after <italic>M. pneumoniae</italic> infection were reviewed to summarize the clinical presentation, possible mechanisms, clinical survey, treatment, and prognosis of this condition. We propose that a <italic>Mycoplasma</italic> profile is necessary in children who present with ON, especially when this condition is accompanied by prodromal symptoms of the respiratory tract infection.</p>
      </abstract>
      <kwd-group>
        <kwd>Bilateral</kwd>
        <kwd>monosymptomatic optic neuritis</kwd>
        <kwd>
          <italic>Mycoplasma pneumoniae</italic>
        </kwd>
        <kwd>retro-bulbar optic neuritis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>The <italic>Mycoplasma pneumoniae</italic> (<italic>M. pneumoniae</italic>) pathogen can cause atypical pneumonia that is occasionally accompanied by extrapulmonary infections. Ocular manifestations other than conjunctivitis are uncommon.[<xref rid="ref1" ref-type="bibr">1</xref>] <italic>M. pneumoniae</italic> infection with optic neuritis (ON) as the only presentation is relatively rare. We describe the case of an 8-year-old boy who developed monosymptomatic ON following <italic>M. pneumoniae</italic> infection along with the clinical findings, treatment approach, management, and prognosis. In addition, the literature on ocular and central nervous system (CNS) manifestations associated with this pathogen were collected and summarized to provide essential information about such cases.</p>
    <sec id="sec1-1">
      <title>Case Report</title>
      <p>An 8-year-old boy with the underlying condition of prematurity had normal developmental milestones. He presented with sudden onset, profoundly blurred vision (oculus uterque [OU]) accompanied by prodromal symptoms of upper respiratory infection.</p>
      <p>Initial ocular examination revealed that his best-corrected visual acuity (BCVA) had deteriorated to light perception only (oculus dexter [OD])/hand motion (HM) at 70-80 cm (oculus sinister [OS]), a fixed and dilated pupil (6.0 mm), and normal fundus appearance [<xref ref-type="fig" rid="F1">Fig. 1</xref>]. Pediatric neurologists did not find neurological symptoms or signs. A visual field (VF) examination could not be performed because of severe visual loss. Optic coherence tomography [<xref ref-type="fig" rid="F2">Fig. 2</xref>] revealed that the retinal nerve fiber layer thicknesses were within the normal range. The visual evoked potential (VEP) [<xref ref-type="fig" rid="F3">Fig. 3</xref>] showed severe prolonged latency (OU). The brain magnetic resonance image (MRI) did not show a brain lesion nor optic nerve enhancement in the T1-weighted image with contrast. Laboratory analyses revealed a high <italic>Mycoplasma</italic>-IgM titer (+, &gt;75 BU/mL) in his blood, but the glucose (62 mg/dL) and total protein (18.6 mg/dL) levels in his cerebrospinal fluid (CSF) were within normal limits. Based on the profile above, bilateral ON associated with <italic>M. pneumoniae</italic> infection was suspected.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Color fundus did not reveal papillitis or an active retinal lesion</p>
        </caption>
        <graphic xlink:href="IJO-62-724-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Disc optical coherence tomography (OCT). Disc OCT revealed normal bilateral disc appearance and nerve fiber layer thickness</p>
        </caption>
        <graphic xlink:href="IJO-62-724-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Visual evoked potential (VEP). Pattern VEP showed a severely prolonged latency and aberrant waves</p>
        </caption>
        <graphic xlink:href="IJO-62-724-g003"/>
      </fig>
      <p>A pulse steroid therapy of intravenous methylprednisolone (750 mg/day) was given for 3 days followed by oral prednisolone (10 mg/day). However, because the BCVA persisted at HM (OU) after the 3-day pulse therapy, an intravenous immunoglobulin (1 g/kg&#xB7;day) was prescribed for 2 days. After the 3-day pulse therapy, the initially fixed and dilated pupil (size, 6.0 mm) responded to light (size, 3.5 mm), but a relative afferent pupillary defect (RAPD) was still noted in the right eye. His BCVA improved to 12/20 (OD), 6/20 (OS) and the VF [<xref ref-type="fig" rid="F4">Fig. 4a</xref>] showed a severely constricted VF with a central tunnel (OD)/inferior arcuate VF defect (OS) 2 weeks after pulse therapy. His visual outcome dramatically improved with a BCVA of 20/20 (OD), 20/20 (OS) and an improved VF result 7 weeks after treatment [<xref ref-type="fig" rid="F4">Fig. 4b</xref>], and these factors improved further at 15 weeks after treatment [<xref ref-type="fig" rid="F4">Fig. 4c</xref>].</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Visual field (VF) after treatment. Initially 2 weeks after treatment (a), a VF defect was noted with a severely constricted VF with a central tunnel (oculus dexter)/inferior arcuate VF defect (oculus sinister). Progressive improvement was noted 7 weeks after treatment (b) and 15 weeks after treatment (c)</p>
        </caption>
        <graphic xlink:href="IJO-62-724-g004"/>
      </fig>
    </sec>
    <sec sec-type="discussion" id="sec1-2">
      <title>Discussion</title>
      <p>ON, which is strongly associated with multiple sclerosis, infectious causes should be given a high priority in young patients. A review article indicated that specific infectious pathogens such as measles, mumps, chickenpox, rubella, brucella, pertussis, mononucleosis, and Epstein-Barr virus have been reported for pediatric ON; furthermore, this review proposed that postinfectious ON is the result of an autoimmune reaction to the infection.[<xref rid="ref2" ref-type="bibr">2</xref>]</p>
      <p>Bilateral involvement with profound visual loss is more common in ON in children than in adults.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>] Symptoms may include RAPD, headache, eye pain, or bilateral papillitis.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref4" ref-type="bibr">4</xref>] The VEP signal may initially present as an absent or diminished amplitude, with a more abnormal latency than is observed in adults.[<xref rid="ref2" ref-type="bibr">2</xref>]</p>
      <p><italic>M. pneumoniae</italic> is an atypical pathogen that mainly causes respiratory infection and is among the most important bacterial causes of &#x201C;atypical&#x201D; community-acquired pneumonia with overall prevalence of 22.7%.[<xref rid="ref5" ref-type="bibr">5</xref>] However, <italic>M. pneumoniae</italic> is also responsible for extrapulmonary symptoms. The most common extrapulmonary complications of <italic>M. pneumoniae</italic> are neurological,[<xref rid="ref6" ref-type="bibr">6</xref>] such as encephalitis, myelitis, and central white matter disease.[<xref rid="ref7" ref-type="bibr">7</xref>] It may also show ocular involvement such as conjunctivitis, third or sixth nerve palsies, homonymous hemianopia, nystagmus, anterior uveitis, and very rarely, optic neuropathy.[<xref rid="ref1" ref-type="bibr">1</xref>] Although the primary diagnosis of <italic>M. pneumoniae</italic>-associated disease is based on clinical presentation, elevated immunoglobulin titers in the serum are an acceptable diagnostic confirmation in clinical practice.[<xref rid="ref6" ref-type="bibr">6</xref>]</p>
      <p>Due to the rare incidence of ON associated with <italic>M. pneumoniae</italic> infection, we reviewed articles about ON after <italic>M. pneumoniae</italic> infection published from 1998 to 2011 [<xref ref-type="table" rid="T1">Table 1</xref>]. In total, five patients with <italic>M. pneumoniae</italic>-induced ON reported in the available literature.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] The following characteristics were noted: All cases had prodromal symptoms of respiratory tract infection,[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] only two ON cases occurred in children;[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref8" ref-type="bibr">8</xref>] four cases had bilateral profound visual loss[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>], one case had a VF defect of disclosed marked restriction,[<xref rid="ref6" ref-type="bibr">6</xref>] four cases did not have a light reflex;[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref8" ref-type="bibr">8</xref>] three cases had papillitis,[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref9" ref-type="bibr">9</xref>] and two cases had abnormal MRI findings.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref9" ref-type="bibr">9</xref>] Compared to the patients listed in <xref ref-type="table" rid="T1">Table 1</xref>, our patient was the first to present with monosymptomatic visual loss without papillitis, neurological symptoms, and an abnormal MRI; furthermore, papillitis is the common presentation of ON in children, but our patient presented with retro-bulbar form.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Literature review of <italic>M. pneumoniae</italic>-induced optic neuritis with clinical manifestations</p>
        </caption>
        <graphic xlink:href="IJO-62-724-g005"/>
      </table-wrap>
      <p>Direct invasion of the CNS and a postinfectious immune response are among the suggested mechanisms of <italic>M. pneumoniae</italic> extrapulmonary complications.[<xref rid="ref8" ref-type="bibr">8</xref>] Another study suggested an autoimmune mechanism because antibodies to myelin and neural tissue have been detected in some cases and the removal of these antibodies by plasmapheresis ameliorated neurological symptoms.[<xref rid="ref7" ref-type="bibr">7</xref>]</p>
      <p>The ON treatment trial[<xref rid="ref10" ref-type="bibr">10</xref>] suggests intravenous administration of methylprednisolone followed by oral prednisolone for a fast recovery and low recurrence, but no effect on final visual outcome. Although the management of ON is well-described in adults, evidence-based, prospective clinical data on its management and treatment in a pediatric population is scarce.[<xref rid="ref4" ref-type="bibr">4</xref>] The current treatment of pediatric ON, consisting of 3-5 days of intravenous methylprednisolone (4-30 mg/kg&#xB7;day) followed by oral corticosteroid.[<xref rid="ref4" ref-type="bibr">4</xref>] The alternative treatment includes intravenous administration of immunoglobulin and plasmapheresis while being refractory to corticosteroid. However, the effect of immunomodulation on visual recovery has not been established. As for our patient, improvement could not be recognized as the attribution to steroid or immunoglobulin therapy.</p>
      <p>Regarding the prognosis of pediatric ON, visual recovery is excellent in most cases, especially in younger children (&lt;6 years of age).[<xref rid="ref3" ref-type="bibr">3</xref>] In our patient, the clinical course of ON presumably due to <italic>M. pneumoniae</italic> infection was recovery of the pupil response to light 3 days after pulse therapy and an improvement of the VA to the normal range in 7 weeks; however, the VF defect persisted 2 months after ON onset.</p>
    </sec>
    <sec sec-type="conclusion" id="sec1-3">
      <title>Conclusion</title>
      <p><italic>Mycoplasma</italic> infection-induced monosymptomatic ON is rare. Evaluation of anti-<italic>Mycoplasma</italic> antibodies (IgM and IgG) and a CNS survey (MRI and CSF study) should be performed routinely when ON is suspected, especially in children. Immunomodulatory therapy may be considered after a poor response to methylprednisolone pulse therapy. The visual outcome was favorable in our case with recovery of visual acuity 2 months after treatment.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> None declared</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zografos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Piguet</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Bilateral optic papillitis following <italic>Mycoplasma pneumoniae pneumonia</italic></article-title>
          <source>Ophthalmologica</source>
          <year>1998</year>
          <volume>212</volume>
          <fpage>344</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">9693295</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Dairi</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ghasia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bhatti</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Pediatric optic neuritis</article-title>
          <source>Int Ophthalmol Clin</source>
          <year>2012</year>
          <volume>52</volume>
          <fpage>29</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">22668538</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brady</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Brar</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Coats</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Paysse</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Steinkuller</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Optic neuritis in children: Clinical features and visual outcome</article-title>
          <source>J AAPOS</source>
          <year>1999</year>
          <volume>3</volume>
          <fpage>98</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="pmid">10221803</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonhomme</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>Treatment of pediatric optic neuritis</article-title>
          <source>Curr Treat Options Neurol</source>
          <year>2012</year>
          <volume>14</volume>
          <fpage>93</fpage>
          <lpage>102</lpage>
          <pub-id pub-id-type="pmid">22190178</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Hardy</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Longo</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Infections due to mycoplasmas</article-title>
          <source>Harrison's Principles of Internal Medicine</source>
          <year>2012</year>
          <edition>18th ed</edition>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill Medical</publisher-name>
          <fpage>1417</fpage>
          <lpage>20</lpage>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ginestal</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Plaza</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Callejo</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez-Espinosa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez-Ruiz</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Masju&#xE1;n</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Bilateral optic neuritis and Guillain-Barr&#xE9; syndrome following an acute <italic>Mycoplasma pneumoniae</italic> infection</article-title>
          <source>J Neurol</source>
          <year>2004</year>
          <volume>251</volume>
          <fpage>767</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">15311361</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pfausler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Engelhardt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kampfl</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Spiss</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Taferner</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schmutzhard</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Post-infectious central and peripheral nervous system diseases complicating <italic>Mycoplasma pneumoniae</italic> infection. Report of three cases and review of the literature</article-title>
          <source>Eur J Neurol</source>
          <year>2002</year>
          <volume>9</volume>
          <fpage>93</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">11784383</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Candler</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Dale</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Three cases of central nervous system complications associated with <italic>Mycoplasma pneumoniae</italic></article-title>
          <source>Pediatr Neurol</source>
          <year>2004</year>
          <volume>31</volume>
          <fpage>133</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">15301835</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bae</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>GY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Combined Striatum, Brain Stem, and Optic Nerve Involvement due to <italic>Mycoplasma pneumoniae</italic> in an Ambulatory Child</article-title>
          <source>Case Rep Neurol</source>
          <year>2011</year>
          <volume>3</volume>
          <fpage>109</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">21677880</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beck</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Cleary</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>MM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Keltner</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Shults</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>DI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group</article-title>
          <source>N Engl J Med</source>
          <year>1992</year>
          <volume>326</volume>
          <fpage>581</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">1734247</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
